CIK: 0001637359
Total reported value
$163.1M
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | BCAX | Bicara Therapeutics INC | Stock-Other | 35.09% | +16.21% | — | |
| 2 | NUVB | Nuvation Bio INC | Stock-Other | 18.71% | -4.02% | -1.53% | |
| 3 | REPL | Replimune Group INC | Stock-Other | 16.86% | +0.33% | — | |
| 4 | LXEO | Lexeo Therapeutics INC | Stock-Other | 13.31% | — | — | |
| 5 | ✓ | Engene Holdings INC | Stock-Other | 4.44% | +0.90% | — | |
| 6 | ALMS | Alumis INC | Stock-Other | 4.36% | +1.03% | -0.00% | |
| 7 | ✓ | Ikena Oncology INC | Stock-Other | 2.43% | — | — | |
| 8 | SANA | Sana Biotechnology INC | Stock-Other | 2.19% | +0.29% | — | |
| 9 | VTLUSD | Immunic INC | Stock-Other | 1.84% | — | — | |
| 10 | ✓ | Engene Holdings INC | Stock-Other | 0.42% | — | — | |
| 11 | SYRS | Syros Pharmaceuticals INC | Stock-Other | 0.34% | — | — |